1. Gary E. Marchant, Douglas J. Sylvester & Kenneth W. Abbott (2009). What Does the History of Technology Regulation Teach Us About Nano Oversight? Journal of Law, Medicine and Ethics 37 (4):724-731.
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  2. Gary E. Marchant, Douglas J. Sylvester, Kenneth W. Abbott & Tara Lynn Danforth (2009). International Harmonization of Regulation of Nanomedicine. Studies in Ethics, Law, and Technology 3 (3).
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  3. Gary E. Marchant, Douglas J. Sylvester & Kenneth W. Abbott (2008). Risk Management Principles for Nanotechnology. NanoEthics 2 (1):43-60.
    Risk management of nanotechnology is challenged by the enormous uncertainties about the risks, benefits, properties, and future direction of nanotechnology applications. Because of these uncertainties, traditional risk management principles such as acceptable risk, cost–benefit analysis, and feasibility are unworkable, as is the newest risk management principle, the precautionary principle. Yet, simply waiting for these uncertainties to be resolved before undertaking risk management efforts would not be prudent, in part because of the growing public concerns about nanotechnology driven by risk perception (...)
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation